What Know About This Fund’s AI Stock Sale Now Up 37%
A major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
This brief overview contrasts lifecycle funds with target date funds, highlighting key distinctions to help you choose the right fund for retirement planning.
18,693 articlesA major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A leading home-health provider delivered a 74% rise over 12 months, while a prominent fund expanded its ownership to ...
When a hedge fund takes position in a logistics stock, it often signals confidence in the sector's growth prospects a...
A leading investment fund recently opened a sizable stake in STGW after marquee client wins. Here’s what this move co...
Two popular bank-focused ETFs offer different paths to tap the U.S. financial sector. This piece breaks down broad ba...
A notable ETF move has real implications for investors. Burkett Financial's latest stake in JEMA offers insight into ...
In a move that stirs controversy, a $1.7 billion fund is being created to compensate allies in a settlement tied to T...
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....
UK regulators propose a narrow path for crypto exposure inside mainstream funds. A 10% cap on crypto ETNs could let m...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...